25 XP   0   0   10

Melexis NV
Buy, Hold or Sell?

Let's analyse Melexis together

PenkeI guess you are interested in Melexis NV. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Melexis NV. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Melexis NV

I send you an email if I find something interesting about Melexis NV.

Quick analysis of Melexis (30 sec.)










What can you expect buying and holding a share of Melexis? (30 sec.)

How much money do you get?

How much money do you get?
€3.76
When do you have the money?
1 year
How often do you get paid?
62.5%

What is your share worth?

Current worth
€13.69
Expected worth in 1 year
€15.38
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
€5.18
Return On Investment
5.9%

For what price can you sell your share?

Current Price per Share
€87.10
Expected price per share
€63.52 - €88.64
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Melexis (5 min.)




Live pricePrice per Share (EOD)

€87.10

Intrinsic Value Per Share

€-7.45 - €9.24

Total Value Per Share

€6.24 - €22.93

2. Growth of Melexis (5 min.)




Is Melexis growing?

Current yearPrevious yearGrowGrow %
How rich?$595.5m$470m$85.2m15.4%

How much money is Melexis making?

Current yearPrevious yearGrowGrow %
Making money$57m$47.9m$9m15.8%
Net Profit Margin22.6%22.9%--

How much money comes from the company's main activities?

3. Financial Health of Melexis (5 min.)




4. Comparing to competitors in the Semiconductors industry (5 min.)




  Industry Rankings (Semiconductors)  


Richest
#87 / 271

Most Revenue
#58 / 271

Most Profit
#38 / 271
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Melexis? (5 min.)

Welcome investor! Melexis's management wants to use your money to grow the business. In return you get a share of Melexis.

What can you expect buying and holding a share of Melexis?

First you should know what it really means to hold a share of Melexis. And how you can make/lose money.

Speculation

The Price per Share of Melexis is €87.10. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Melexis.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Melexis, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €13.69. Based on the TTM, the Book Value Change Per Share is €0.42 per quarter. Based on the YOY, the Book Value Change Per Share is €0.49 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.87 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Melexis.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps1.511.7%1.411.6%1.191.4%0.861.0%0.760.9%
Usd Book Value Change Per Share1.581.8%0.450.5%0.530.6%0.270.3%0.260.3%
Usd Dividend Per Share0.000.0%0.941.1%1.051.2%1.141.3%0.790.9%
Usd Total Gains Per Share1.581.8%1.391.6%1.571.8%1.421.6%1.051.2%
Usd Price Per Share87.97-96.63-88.09-81.46-71.26-
Price to Earnings Ratio14.52-17.22-19.62-29.35-26.05-
Price-to-Total Gains Ratio55.82-69.90-67.58-75.00-41.11-
Price to Book Ratio5.97-7.05-7.73-7.86-8.24-
Price-to-Total Gains Ratio55.82-69.90-67.58-75.00-41.11-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share93.78057
Number of shares10
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.941.14
Usd Book Value Change Per Share0.450.27
Usd Total Gains Per Share1.391.42
Gains per Quarter (10 shares)13.9514.18
Gains per Year (10 shares)55.8056.74
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1381846461147
275361029222104
31135515813733161
41507321418344218
51889127022955275
622610932627566332
726312738232077389
830114643836688446
933816449441299503
10376182550458110560

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%55.02.00.096.5%
Book Value Change Per Share2.02.00.050.0%6.06.00.050.0%11.09.00.055.0%24.016.00.060.0%37.018.02.064.9%
Dividend per Share2.00.02.050.0%9.00.03.075.0%17.00.03.085.0%25.00.015.062.5%25.00.032.043.9%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%36.04.00.090.0%49.06.02.086.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Melexis

About Melexis NV

Melexis NV designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle-East, Africa, the Asia Pacific, and North and Latin America. The company provides magnetic position, latch and switch, current, inductive position, tire monitoring, temperature, optical, pressure, and speed sensor ICs. It also offers embedded motor driver, fan and pump, LED, and pre driver ICs; and LIN transceiver, CAN transceiver, RFID Transceiver NFC Sensor tag ICs. The company was founded in 1988 and is headquartered in Ieper, Belgium. Melexis NV is a subsidiary of Xtrion N.V.

Fundamental data was last updated by Penke on 2023-12-01 02:05:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is overpriced.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Melexis NV.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Melexis earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Melexis to the Semiconductors industry mean.
  • A Net Profit Margin of 22.9% means that €0.23 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Melexis NV:

  • The MRQ is 22.9%. The company is making a huge profit. +2
  • The TTM is 22.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ22.9%TTM22.6%+0.3%
TTM22.6%YOY22.9%-0.3%
TTM22.6%5Y18.3%+4.3%
5Y18.3%10Y20.5%-2.2%
Compared to industry (Semiconductors)
PeriodCompanyIndustry (mean)+/- 
MRQ22.9%7.3%+15.6%
TTM22.6%5.8%+16.8%
YOY22.9%14.0%+8.9%
5Y18.3%8.4%+9.9%
10Y20.5%7.8%+12.7%
1.1.2. Return on Assets

Shows how efficient Melexis is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Melexis to the Semiconductors industry mean.
  • 7.1% Return on Assets means that Melexis generated €0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Melexis NV:

  • The MRQ is 7.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 7.8%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ7.1%TTM7.8%-0.7%
TTM7.8%YOY8.5%-0.7%
TTM7.8%5Y6.1%+1.7%
5Y6.1%10Y6.8%-0.7%
Compared to industry (Semiconductors)
PeriodCompanyIndustry (mean)+/- 
MRQ7.1%1.1%+6.0%
TTM7.8%0.8%+7.0%
YOY8.5%2.2%+6.3%
5Y6.1%1.6%+4.5%
10Y6.8%1.6%+5.2%
1.1.3. Return on Equity

Shows how efficient Melexis is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Melexis to the Semiconductors industry mean.
  • 10.3% Return on Equity means Melexis generated €0.10 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Melexis NV:

  • The MRQ is 10.3%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 10.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ10.3%TTM10.3%0.0%
TTM10.3%YOY10.2%+0.1%
TTM10.3%5Y7.8%+2.5%
5Y7.8%10Y8.7%-0.9%
Compared to industry (Semiconductors)
PeriodCompanyIndustry (mean)+/- 
MRQ10.3%1.6%+8.7%
TTM10.3%1.3%+9.0%
YOY10.2%3.7%+6.5%
5Y7.8%2.6%+5.2%
10Y8.7%2.6%+6.1%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Melexis NV.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Melexis is operating .

  • Measures how much profit Melexis makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Melexis to the Semiconductors industry mean.
  • An Operating Margin of 28.6% means the company generated €0.29  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Melexis NV:

  • The MRQ is 28.6%. The company is operating very efficient. +2
  • The TTM is 27.4%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ28.6%TTM27.4%+1.2%
TTM27.4%YOY28.5%-1.1%
TTM27.4%5Y21.8%+5.7%
5Y21.8%10Y24.0%-2.2%
Compared to industry (Semiconductors)
PeriodCompanyIndustry (mean)+/- 
MRQ28.6%7.9%+20.7%
TTM27.4%2.2%+25.2%
YOY28.5%12.3%+16.2%
5Y21.8%9.2%+12.6%
10Y24.0%6.9%+17.1%
1.2.2. Operating Ratio

Measures how efficient Melexis is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Semiconductors industry mean).
  • An Operation Ratio of 0.71 means that the operating costs are €0.71 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Melexis NV:

  • The MRQ is 0.714. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.726. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.714TTM0.726-0.012
TTM0.726YOY0.737-0.011
TTM0.7265Y0.789-0.063
5Y0.78910Y0.765+0.024
Compared to industry (Semiconductors)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7141.574-0.860
TTM0.7261.564-0.838
YOY0.7371.387-0.650
5Y0.7891.509-0.720
10Y0.7651.298-0.533
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Melexis NV.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Melexis is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Semiconductors industry mean).
  • A Current Ratio of 3.72 means the company has €3.72 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Melexis NV:

  • The MRQ is 3.720. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.269. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.720TTM4.269-0.549
TTM4.269YOY4.441-0.171
TTM4.2695Y4.663-0.394
5Y4.66310Y4.200+0.463
Compared to industry (Semiconductors)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7202.745+0.975
TTM4.2692.722+1.547
YOY4.4412.593+1.848
5Y4.6632.647+2.016
10Y4.2002.379+1.821
1.3.2. Quick Ratio

Measures if Melexis is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Melexis to the Semiconductors industry mean.
  • A Quick Ratio of 1.48 means the company can pay off €1.48 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Melexis NV:

  • The MRQ is 1.478. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 2.077. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.478TTM2.077-0.600
TTM2.077YOY2.355-0.278
TTM2.0775Y2.297-0.220
5Y2.29710Y1.979+0.318
Compared to industry (Semiconductors)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4780.980+0.498
TTM2.0770.899+1.178
YOY2.3551.070+1.285
5Y2.2971.119+1.178
10Y1.9791.132+0.847
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Melexis NV.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Melexis assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Melexis to Semiconductors industry mean.
  • A Debt to Asset Ratio of 0.31 means that Melexis assets are financed with 30.7% credit (debt) and the remaining percentage (100% - 30.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Melexis NV:

  • The MRQ is 0.307. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.244. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.307TTM0.244+0.064
TTM0.244YOY0.166+0.078
TTM0.2445Y0.225+0.019
5Y0.22510Y0.225+0.000
Compared to industry (Semiconductors)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3070.323-0.016
TTM0.2440.327-0.083
YOY0.1660.347-0.181
5Y0.2250.360-0.135
10Y0.2250.359-0.134
1.4.2. Debt to Equity Ratio

Measures if Melexis is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Melexis to the Semiconductors industry mean.
  • A Debt to Equity ratio of 44.4% means that company has €0.44 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Melexis NV:

  • The MRQ is 0.444. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.336. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.444TTM0.336+0.108
TTM0.336YOY0.199+0.137
TTM0.3365Y0.297+0.039
5Y0.29710Y0.294+0.003
Compared to industry (Semiconductors)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4440.478-0.034
TTM0.3360.506-0.170
YOY0.1990.550-0.351
5Y0.2970.587-0.290
10Y0.2940.606-0.312
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Melexis NV

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Melexis generates.

  • Above 15 is considered overpriced but always compare Melexis to the Semiconductors industry mean.
  • A PE ratio of 14.52 means the investor is paying €14.52 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Melexis NV:

  • The EOD is 15.484. Based on the earnings, the company is fair priced.
  • The MRQ is 14.524. Based on the earnings, the company is underpriced. +1
  • The TTM is 17.219. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD15.484MRQ14.524+0.960
MRQ14.524TTM17.219-2.695
TTM17.219YOY19.619-2.400
TTM17.2195Y29.351-12.133
5Y29.35110Y26.049+3.302
Compared to industry (Semiconductors)
PeriodCompanyIndustry (mean)+/- 
EOD15.48417.294-1.810
MRQ14.52416.118-1.594
TTM17.21916.016+1.203
YOY19.61913.588+6.031
5Y29.35119.020+10.331
10Y26.04919.730+6.319
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Melexis NV:

  • The EOD is 163.911. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 153.749. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 76.461. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD163.911MRQ153.749+10.162
MRQ153.749TTM76.461+77.288
TTM76.461YOY23.444+53.017
TTM76.4615Y86.963-10.501
5Y86.96310Y57.198+29.765
Compared to industry (Semiconductors)
PeriodCompanyIndustry (mean)+/- 
EOD163.9119.329+154.582
MRQ153.7498.223+145.526
TTM76.4615.908+70.553
YOY23.4447.540+15.904
5Y86.9634.219+82.744
10Y57.1984.422+52.776
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Melexis is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Semiconductors industry mean).
  • A PB ratio of 5.97 means the investor is paying €5.97 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Melexis NV:

  • The EOD is 6.362. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.968. Based on the equity, the company is overpriced. -1
  • The TTM is 7.047. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD6.362MRQ5.968+0.394
MRQ5.968TTM7.047-1.080
TTM7.047YOY7.727-0.680
TTM7.0475Y7.857-0.810
5Y7.85710Y8.244-0.387
Compared to industry (Semiconductors)
PeriodCompanyIndustry (mean)+/- 
EOD6.3622.751+3.611
MRQ5.9682.592+3.376
TTM7.0472.496+4.551
YOY7.7272.945+4.782
5Y7.8573.169+4.688
10Y8.2443.275+4.969
2. Total Gains per Share

2.4. Latest News of Melexis NV

Does Melexis NV still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Melexis NV to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2023-11-20
17:40
Melexis Transparency NotificationRead
2023-11-14
19:00
Changes to the Shareholding StructureRead
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Melexis NV compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.4640.423+246%0.489+199%0.255+474%0.238+516%
Book Value Per Share--13.69112.754+7%10.786+27%9.745+40%8.082+69%
Current Ratio--3.7204.269-13%4.441-16%4.663-20%4.200-11%
Debt To Asset Ratio--0.3070.244+26%0.166+85%0.225+37%0.225+37%
Debt To Equity Ratio--0.4440.336+32%0.199+123%0.297+49%0.294+51%
Dividend Per Share---0.873-100%0.972-100%1.063-100%0.734-100%
Eps--1.4061.309+7%1.101+28%0.798+76%0.704+100%
Free Cash Flow Per Share--0.133-0.454+442%0.975-86%0.390-66%0.385-66%
Free Cash Flow To Equity Per Share---0.133-0.533+301%0.250-153%-0.039-71%-0.021-84%
Gross Profit Margin--0.9150.902+1%0.878+4%0.837+9%0.864+6%
Intrinsic Value_10Y_max--9.241--------
Intrinsic Value_10Y_min---7.447--------
Intrinsic Value_1Y_max--1.454--------
Intrinsic Value_1Y_min--1.102--------
Intrinsic Value_3Y_max--3.965--------
Intrinsic Value_3Y_min--1.730--------
Intrinsic Value_5Y_max--5.992--------
Intrinsic Value_5Y_min--0.620--------
Market Cap3518840000.000+6%3300680000.0003629457894.850-9%3313042810.6000%3063179698.555+8%2680431118.636+23%
Net Profit Margin--0.2290.226+1%0.2290%0.183+25%0.205+11%
Operating Margin--0.2860.274+4%0.285+0%0.218+32%0.240+19%
Operating Ratio--0.7140.726-2%0.737-3%0.789-9%0.765-7%
Pb Ratio6.362+6%5.9687.047-15%7.727-23%7.857-24%8.244-28%
Pe Ratio15.484+6%14.52417.219-16%19.619-26%29.351-51%26.049-44%
Price Per Share87.100+6%81.70089.750-9%81.8130%75.653+8%66.185+23%
Price To Free Cash Flow Ratio163.911+6%153.74976.461+101%23.444+556%86.963+77%57.198+169%
Price To Total Gains Ratio59.508+6%55.81969.896-20%67.585-17%75.005-26%41.107+36%
Quick Ratio--1.4782.077-29%2.355-37%2.297-36%1.979-25%
Return On Assets--0.0710.078-8%0.085-16%0.061+17%0.068+5%
Return On Equity--0.1030.1030%0.102+1%0.078+32%0.087+18%
Total Gains Per Share--1.4641.296+13%1.462+0%1.317+11%0.972+51%
Usd Book Value--595527076.800555298603.875+7%470028929.615+27%424749211.883+40%352344348.248+69%
Usd Book Value Change Per Share--1.5760.455+246%0.527+199%0.274+474%0.256+516%
Usd Book Value Per Share--14.74113.732+7%11.613+27%10.492+40%8.702+69%
Usd Dividend Per Share---0.940-100%1.047-100%1.144-100%0.790-100%
Usd Eps--1.5141.410+7%1.186+28%0.859+76%0.758+100%
Usd Free Cash Flow--5778648.900-19874536.125+444%42465394.428-86%17002611.524-66%16784000.132-66%
Usd Free Cash Flow Per Share--0.143-0.489+442%1.049-86%0.420-66%0.415-66%
Usd Free Cash Flow To Equity Per Share---0.143-0.573+301%0.269-153%-0.042-71%-0.023-84%
Usd Market Cap3788735028.000+6%3553842156.0003907837315.385-9%3567153194.1730%3298125581.434+8%2886020185.435+23%
Usd Price Per Share93.781+6%87.96696.634-9%88.0880%81.455+8%71.261+23%
Usd Profit--61171633.80057012072.525+7%47987231.267+27%34771989.515+76%30686448.566+99%
Usd Revenue--267614861.700252398937.300+6%209555973.253+28%179257719.020+49%148937424.927+80%
Usd Total Gains Per Share--1.5761.395+13%1.574+0%1.418+11%1.046+51%
 EOD+4 -4MRQTTM+23 -13YOY+18 -185Y+22 -1410Y+23 -13

3.2. Fundamental Score

Let's check the fundamental score of Melexis NV based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1515.484
Price to Book Ratio (EOD)Between0-16.362
Net Profit Margin (MRQ)Greater than00.229
Operating Margin (MRQ)Greater than00.286
Quick Ratio (MRQ)Greater than11.478
Current Ratio (MRQ)Greater than13.720
Debt to Asset Ratio (MRQ)Less than10.307
Debt to Equity Ratio (MRQ)Less than10.444
Return on Equity (MRQ)Greater than0.150.103
Return on Assets (MRQ)Greater than0.050.071
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Melexis NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5067.066
Ma 20Greater thanMa 5082.433
Ma 50Greater thanMa 10079.254
Ma 100Greater thanMa 20082.811
OpenGreater thanClose86.650
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets798,671
Total Liabilities245,567
Total Stockholder Equity553,104
 As reported
Total Liabilities 245,567
Total Stockholder Equity+ 553,104
Total Assets = 798,671

Assets

Total Assets798,671
Total Current Assets411,151
Long-term Assets411,151
Total Current Assets
Cash And Cash Equivalents 30,523
Short-term Investments 246
Net Receivables 132,272
Inventory 227,365
Other Current Assets 20,745
Total Current Assets  (as reported)411,151
Total Current Assets  (calculated)411,151
+/-0
Long-term Assets
Property Plant Equipment 178,736
Long-term Assets Other 176,125
Long-term Assets  (as reported)387,520
Long-term Assets  (calculated)354,861
+/- 32,659

Liabilities & Shareholders' Equity

Total Current Liabilities110,511
Long-term Liabilities135,056
Total Stockholder Equity553,104
Total Current Liabilities
Short-term Debt 448
Accounts payable 31,747
Other Current Liabilities 14,841
Total Current Liabilities  (as reported)110,511
Total Current Liabilities  (calculated)47,036
+/- 63,475
Long-term Liabilities
Long term Debt 126,853
Capital Lease Obligations Min Short Term Debt3,110
Long-term Liabilities Other 4,904
Long-term Liabilities  (as reported)135,056
Long-term Liabilities  (calculated)134,867
+/- 189
Total Stockholder Equity
Common Stock565
Retained Earnings 555,992
Other Stockholders Equity -3,453
Total Stockholder Equity (as reported)553,104
Total Stockholder Equity (calculated)553,104
+/-0
Other
Capital Stock565
Cash and Short Term Investments 30,769
Common Stock Shares Outstanding 40,294
Current Deferred Revenue63,475
Liabilities and Stockholders Equity 798,671
Net Debt 99,888
Net Invested Capital 679,957
Net Working Capital 300,640
Short Long Term Debt Total 130,411



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
> Total Assets 
0
0
0
154,252
160,387
170,636
181,144
180,479
179,986
187,051
192,232
178,103
184,137
196,911
209,948
195,570
209,322
206,840
224,490
214,817
232,867
249,555
276,079
256,773
283,977
309,163
340,072
306,770
333,263
343,450
362,748
358,165
382,706
380,132
416,237
403,361
418,794
404,924
435,118
428,019
432,675
436,659
453,893
418,610
442,857
442,906
454,829
433,412
464,637
465,313
478,888
461,180
527,314
522,667
582,903
580,233
640,788
738,906
798,671
798,671738,906640,788580,233582,903522,667527,314461,180478,888465,313464,637433,412454,829442,906442,857418,610453,893436,659432,675428,019435,118404,924418,794403,361416,237380,132382,706358,165362,748343,450333,263306,770340,072309,163283,977256,773276,079249,555232,867214,817224,490206,840209,322195,570209,948196,911184,137178,103192,232187,051179,986180,479181,144170,636160,387154,252000
   > Total Current Assets 
0
0
0
89,820
94,794
105,336
114,159
110,359
107,671
112,818
118,038
105,022
108,111
120,050
131,592
113,067
123,717
120,009
134,910
128,187
146,053
161,288
186,077
166,103
190,438
211,147
237,819
198,140
223,470
231,555
253,424
230,562
254,332
244,633
273,575
254,338
258,032
233,776
254,775
240,452
243,387
251,115
271,694
237,328
264,832
270,433
287,002
263,389
293,387
295,721
309,241
291,862
364,804
361,335
417,904
407,735
459,936
405,620
411,151
411,151405,620459,936407,735417,904361,335364,804291,862309,241295,721293,387263,389287,002270,433264,832237,328271,694251,115243,387240,452254,775233,776258,032254,338273,575244,633254,332230,562253,424231,555223,470198,140237,819211,147190,438166,103186,077161,288146,053128,187134,910120,009123,717113,067131,592120,050108,111105,022118,038112,818107,671110,359114,159105,33694,79489,820000
       Cash And Cash Equivalents 
0
0
0
22,247
19,349
26,120
32,153
21,180
18,560
24,651
36,750
17,806
25,705
25,137
38,496
21,317
16,496
16,426
31,559
27,722
34,747
53,334
78,080
59,610
58,810
80,931
109,821
73,838
89,981
95,321
109,201
75,789
92,045
78,041
109,157
75,478
71,798
28,763
36,946
34,522
39,554
31,307
60,150
38,772
51,051
57,622
78,831
58,883
76,913
58,967
51,799
34,950
57,799
39,270
104,460
85,080
93,259
35,710
30,523
30,52335,71093,25985,080104,46039,27057,79934,95051,79958,96776,91358,88378,83157,62251,05138,77260,15031,30739,55434,52236,94628,76371,79875,478109,15778,04192,04575,789109,20195,32189,98173,838109,82180,93158,81059,61078,08053,33434,74727,72231,55916,42616,49621,31738,49625,13725,70517,80636,75024,65118,56021,18032,15326,12019,34922,247000
       Short-term Investments 
0
0
0
3,990
4,170
4,112
4,688
5,729
6,821
5,925
4,009
4,605
4,930
3,521
4,160
3,879
4,682
4,671
4,744
3,788
0
0
0
0
149
351
111
0
49
0
137
0
0
2,716
43
0
2
154
0
0
0
14
0
78
2
0
210
245
522
0
7,273
10,356
20,555
23,394
12,096
12,501
12,271
0
246
246012,27112,50112,09623,39420,55510,3567,2730522245210027801400015420432,71600137049011135114900003,7884,7444,6714,6823,8794,1603,5214,9304,6054,0095,9256,8215,7294,6884,1124,1703,990000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
76,405
70,287
79,813
67,323
79,347
74,302
85,999
80,415
82,908
65,678
68,457
69,691
66,873
71,058
58,131
65,380
77,599
80,014
100,149
107,104
99,098
94,195
100,710
98,927
107,547
143,463
134,903
132,272
132,272134,903143,463107,54798,927100,71094,19599,098107,104100,14980,01477,59965,38058,13171,05866,87369,69168,45765,67882,90880,41585,99974,30279,34767,32379,81370,28776,4050000000000000000000000000000000
       Other Current Assets 
0
0
0
37,188
40,306
42,166
42,761
44,233
44,529
46,103
41,763
45,667
41,184
56,987
53,645
49,513
63,669
60,287
58,319
52,412
63,362
57,687
55,845
50,080
68,698
67,535
63,561
60,203
71,182
70,437
71,040
77,893
82,585
82,230
76,067
81,235
85,461
89,587
91,958
85,363
78,892
90,885
83,569
69,973
83,892
64,441
76,372
80,804
92,194
108,218
118,850
102,065
128,180
18,880
13,951
20,078
19,294
22,248
20,745
20,74522,24819,29420,07813,95118,880128,180102,065118,850108,21892,19480,80476,37264,44183,89269,97383,56990,88578,89285,36391,95889,58785,46181,23576,06782,23082,58577,89371,04070,43771,18260,20363,56167,53568,69850,08055,84557,68763,36252,41258,31960,28763,66949,51353,64556,98741,18445,66741,76346,10344,52944,23342,76142,16640,30637,188000
   > Long-term Assets 
0
0
0
64,432
65,593
65,300
66,985
70,120
72,315
74,233
74,194
73,081
76,026
76,861
78,356
82,503
85,605
86,831
89,580
86,630
86,813
88,267
90,002
90,671
93,538
98,016
102,253
108,630
109,793
111,895
109,323
127,603
128,374
135,499
142,662
149,022
160,762
171,149
180,343
187,567
189,288
185,544
182,199
181,282
178,025
172,473
167,827
170,023
171,250
169,592
169,648
169,319
162,510
161,332
164,999
172,498
180,852
333,286
387,520
387,520333,286180,852172,498164,999161,332162,510169,319169,648169,592171,250170,023167,827172,473178,025181,282182,199185,544189,288187,567180,343171,149160,762149,022142,662135,499128,374127,603109,323111,895109,793108,630102,25398,01693,53890,67190,00288,26786,81386,63089,58086,83185,60582,50378,35676,86176,02673,08174,19474,23372,31570,12066,98565,30065,59364,432000
       Property Plant Equipment 
0
0
0
43,918
44,459
45,064
46,388
48,760
50,815
52,014
51,174
51,354
53,886
54,287
54,898
60,004
63,045
65,540
62,944
66,324
66,560
67,634
69,480
71,733
73,818
79,221
83,033
90,300
92,751
96,454
95,209
97,411
97,591
103,810
107,988
116,780
129,078
110,515
150,456
157,417
159,876
155,651
151,192
148,420
145,200
139,035
134,617
132,680
134,446
133,709
135,163
136,613
133,606
133,276
134,942
139,247
147,868
159,524
178,736
178,736159,524147,868139,247134,942133,276133,606136,613135,163133,709134,446132,680134,617139,035145,200148,420151,192155,651159,876157,417150,456110,515129,078116,780107,988103,81097,59197,41195,20996,45492,75190,30083,03379,22173,81871,73369,48067,63466,56066,32462,94465,54063,04560,00454,89854,28753,88651,35451,17452,01450,81548,76046,38845,06444,45943,918000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
6
6
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000066660000000000000000000000000000000
       Intangible Assets 
0
0
0
1,823
1,801
1,761
1,773
0
1,757
1,676
1,982
1,943
1,866
0
0
2,113
1,888
1,691
4,831
4,727
4,627
4,964
4,834
4,723
6,309
6,219
6,646
7,440
7,245
6,944
6,806
6,209
6,042
6,779
7,343
5,556
5,610
5,370
5,077
5,152
4,926
6,208
5,723
5,209
4,765
5,287
4,748
4,650
0
0
0
4,335
0
0
0
3,049
0
0
0
0003,0490004,3350004,6504,7485,2874,7655,2095,7236,2084,9265,1525,0775,3705,6105,5567,3436,7796,0426,2096,8066,9447,2457,4406,6466,2196,3094,7234,8344,9644,6274,7274,8311,6911,8882,113001,8661,9431,9821,6761,75701,7731,7611,8011,823000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
173,627
176,533
0
0
187,077
196,033
0
0
0
223,790
218,647
23,977
24,735
24,904
27,325
26,687
26,075
25,264
24,810
375,134
24,486
23,685
25,284
27,652
28,060
28,151
28,462
32,693
32,561
31,029
29,902
0
25,050
24,387
26,840
0
0
0
0
000026,84024,38725,050029,90231,02932,56132,69328,46228,15128,06027,65225,28423,68524,486375,13424,81025,26426,07526,68727,32524,90424,73523,977218,647223,790000196,033187,07700176,533173,62700000000000000000000
> Total Liabilities 
0
0
0
94,398
91,828
89,024
85,219
85,024
74,741
73,180
71,532
70,982
67,528
69,588
70,767
66,293
67,825
52,158
54,678
57,178
58,029
53,573
54,991
55,412
63,789
64,587
67,150
64,259
67,614
78,798
72,872
95,701
95,132
88,855
95,271
109,058
95,655
85,398
85,695
102,013
92,333
116,880
117,783
119,540
123,300
113,918
111,435
118,636
90,693
94,430
71,052
72,124
89,431
88,247
98,079
98,150
108,768
243,148
245,567
245,567243,148108,76898,15098,07988,24789,43172,12471,05294,43090,693118,636111,435113,918123,300119,540117,783116,88092,333102,01385,69585,39895,655109,05895,27188,85595,13295,70172,87278,79867,61464,25967,15064,58763,78955,41254,99153,57358,02957,17854,67852,15867,82566,29370,76769,58867,52870,98271,53273,18074,74185,02485,21989,02491,82894,398000
   > Total Current Liabilities 
0
0
0
37,518
46,469
45,632
46,344
44,782
29,501
29,980
31,337
31,146
55,193
64,306
65,351
62,550
41,629
32,346
34,841
37,301
42,195
37,743
39,163
39,480
43,884
44,685
49,045
54,005
54,369
65,516
59,551
82,538
81,937
75,631
82,062
100,015
80,655
70,398
70,694
67,742
54,262
50,922
51,777
54,176
57,845
48,369
45,938
54,307
58,226
60,353
66,881
69,212
82,230
80,804
90,103
88,079
98,249
100,241
110,511
110,511100,24198,24988,07990,10380,80482,23069,21266,88160,35358,22654,30745,93848,36957,84554,17651,77750,92254,26267,74270,69470,39880,655100,01582,06275,63181,93782,53859,55165,51654,36954,00549,04544,68543,88439,48039,16337,74342,19537,30134,84132,34641,62962,55065,35164,30655,19331,14631,33729,98029,50144,78246,34445,63246,46937,518000
       Short-term Debt 
0
0
0
15,168
19,129
19,606
19,578
19,647
4,607
4,650
4,648
4,648
29,607
34,648
34,648
34,648
13,648
4,147
4,121
4,147
4,148
4,148
4,148
4,148
5,154
5,155
5,046
7,046
4,046
4,046
4,046
4,047
4,005
4,005
4,051
6,043
42
48
49
1,040
2,013
675
342
1,825
1,405
942
471
1,633
1,186
892
412
1,718
1,354
917
486
1,710
1,253
894
448
4488941,2531,7104869171,3541,7184128921,1861,6334719421,4051,8253426752,0131,0404948426,0434,0514,0054,0054,0474,0464,0464,0467,0465,0465,1555,1544,1484,1484,1484,1484,1474,1214,14713,64834,64834,64834,64829,6074,6484,6484,6504,60719,64719,57819,60619,12915,168000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,482
15,098
15,304
4,051
6,112
42
48
49
1,040
1,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000001,0001,0404948426,1124,05115,30415,09815,4820000000000000000000000000000000
       Accounts payable 
0
0
0
11,459
6,587
7,428
7,843
7,274
7,452
7,918
8,141
0
6,337
8,852
9,678
12,329
11,690
11,053
10,570
13,895
10,731
12,787
12,426
13,863
13,181
15,504
14,359
15,247
18,458
21,680
16,088
19,555
18,578
18,903
17,421
22,262
23,017
25,803
20,644
20,785
16,737
16,171
13,665
16,139
15,160
17,137
15,107
18,328
18,253
23,070
22,147
22,668
26,779
23,424
27,609
28,728
34,483
31,360
31,747
31,74731,36034,48328,72827,60923,42426,77922,66822,14723,07018,25318,32815,10717,13715,16016,13913,66516,17116,73720,78520,64425,80323,01722,26217,42118,90318,57819,55516,08821,68018,45815,24714,35915,50413,18113,86312,42612,78710,73113,89510,57011,05311,69012,3299,6788,8526,33708,1417,9187,4527,2747,8437,4286,58711,459000
       Other Current Liabilities 
0
0
0
10,891
20,753
18,598
18,923
17,861
17,442
17,412
18,548
26,498
19,249
20,806
21,025
15,573
16,291
17,146
20,150
19,259
27,316
20,809
22,589
21,469
25,549
24,026
29,640
31,712
31,865
39,790
39,417
58,936
59,354
52,723
60,590
71,710
57,596
44,548
50,001
45,917
35,512
34,076
37,770
36,211
41,280
30,290
30,360
34,346
38,787
36,390
39,471
42,837
52,276
56,463
62,008
57,641
62,513
7,600
14,841
14,8417,60062,51357,64162,00856,46352,27642,83739,47136,39038,78734,34630,36030,29041,28036,21137,77034,07635,51245,91750,00144,54857,59671,71060,59052,72359,35458,93639,41739,79031,86531,71229,64024,02625,54921,46922,58920,80927,31619,25920,15017,14616,29115,57321,02520,80619,24926,49818,54817,41217,44217,86118,92318,59820,75310,891000
   > Long-term Liabilities 
0
0
0
56,880
45,359
43,392
38,875
40,242
45,240
43,200
40,195
39,837
12,335
5,282
5,416
3,743
26,196
19,812
19,837
19,877
15,834
15,830
15,828
15,932
19,905
19,902
18,105
10,254
13,245
13,283
13,321
13,163
13,195
13,224
13,209
9,043
15,000
15,000
15,001
34,271
38,071
65,958
66,006
65,364
65,455
65,549
65,497
64,329
32,467
34,077
4,171
2,912
7,201
7,443
7,976
10,071
10,519
142,907
135,056
135,056142,90710,51910,0717,9767,4437,2012,9124,17134,07732,46764,32965,49765,54965,45565,36466,00665,95838,07134,27115,00115,00015,0009,04313,20913,22413,19513,16313,32113,28313,24510,25418,10519,90219,90515,93215,82815,83015,83419,87719,83719,81226,1963,7435,4165,28212,33539,83740,19543,20045,24040,24238,87543,39245,35956,880000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,070
2,102
2,133
2,165
1
1
0
1
271
280
272
340
337
328
403
397
207
211
211
253
4
4,001
4,148
4,149
0
0
0
0
00004,1494,1484,001425321121120739740332833734027228027110112,1652,1332,1022,0700000000000000000000000000000000
> Total Stockholder Equity
0
0
0
59,844
68,549
81,602
95,915
95,445
105,235
113,861
120,690
107,110
116,599
127,313
139,171
129,267
141,487
154,671
169,802
157,628
174,828
195,971
221,078
201,351
220,178
244,566
272,912
242,500
265,639
264,641
289,866
262,454
287,564
291,266
320,956
294,292
323,129
319,516
349,413
325,996
340,332
319,768
336,100
299,070
319,557
328,988
343,394
314,776
373,944
370,883
407,836
389,056
437,883
434,420
484,824
482,083
532,020
495,758
553,104
553,104495,758532,020482,083484,824434,420437,883389,056407,836370,883373,944314,776343,394328,988319,557299,070336,100319,768340,332325,996349,413319,516323,129294,292320,956291,266287,564262,454289,866264,641265,639242,500272,912244,566220,178201,351221,078195,971174,828157,628169,802154,671141,487129,267139,171127,313116,599107,110120,690113,861105,23595,44595,91581,60268,54959,844000
   Common Stock
0
0
0
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565
565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565565000
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000000000000000000000000000000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity -3,453-3,985-4,704-3,724-1,330-2,959-4,431-4,638-5,083-5,488-5,287-9,874-9,314-8,815-8,570-8,351-8,020-8,988-8,898-9,288-9,486-9,288-9,603-9,654-8,463-10,044-10,977-10,645-10,205-10,237-10,142-10,444-10,086-13,406-12,909-4,592-4,679-5,126-5,079-3,375-3,393-3,501-3,537-4,560-4,219-3,773-33,073-31,565-29,345-25,534-23,441-21,655-20,416-19,493-12,326-25,020000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.